Spinal implant aims to restore body control after paralysis

NCT ID NCT06410001

Recruiting now Disease control Sponsor: University of Minnesota Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an implanted spinal cord stimulator can improve autonomic functions like blood pressure and heart rate in people with chronic cervical spinal cord injury. The device delivers electrical pulses to the spinal cord to help regulate involuntary body processes. The trial will enroll 36 adults with stable, motor-complete injuries between the C4 and C7 vertebrae, and will primarily assess safety while also measuring changes in blood pressure, heart rate, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Epidural spinal cord stimulation device (Abbott Eterna system)
What this could lead to: If successful, this could improve blood pressure control, heart rate, and overall quality of life for people with chronic cervical spinal cord injury.
What could go wrong: This is an early-phase trial with only 36 participants, so results may not apply to everyone. Risks include infection, bleeding, and cerebrospinal fluid leak from the implant procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL SPINAL CORD INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

primary dysautonomia spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL SPINAL CORD INJURY SPINAL CORD INJURY

Contacts and locations

Locations

University of Minnesota
RECRUITING

Minneapolis, Minnesota, 55455, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.